← Open Payments lookup

FARZAD SHOKRI-TABIBZADEH: Open Payments

NPI 1801819180 · PORT WASHINGTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,158 in 49 payments from 13 companies in 2025. Trend: 2023 $1,265 · 2024 $1,374 · 2025 $1,158

Food & beverage: $1,158
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$213
Salix Pharmaceuticals, a division of Bausch Health US, LLC12$201
AstraZeneca Pharmaceuticals LP7$147
Eisai Inc.1$125
Sumitomo Pharma America, Inc.4$104
Amgen Inc.4$100
Lilly USA, LLC3$64
ABBVIE INC.3$57
Novartis Pharmaceuticals Corporation2$55
Lundbeck LLC1$26

Products named: CAPLYTA, XIFAXAN, FARXIGA, Leqembi, GEMTESA, OTEZLA, JARDIANCE, VRAYLAR.

Industry payments across NY — which companies pay providers there.